{"id":12349,"date":"2025-05-09T16:15:58","date_gmt":"2025-05-09T16:15:58","guid":{"rendered":"https:\/\/mecfs-research.org\/?page_id=12349"},"modified":"2026-04-25T18:34:04","modified_gmt":"2026-04-25T18:34:04","slug":"pm-costreport-long-covid-and-mecfs","status":"publish","type":"page","link":"https:\/\/mecfs-research.org\/en\/press\/press-releases\/pm-costreport-long-covid-and-mecfs\/","title":{"rendered":"2025-05 Pressemeldung Impact Studie"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Press release<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Societal cost of Long COVID and ME\/CFS in Germany severely underestimated - \u20ac63 billion in 2024 alone<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Hamburg, 12 May 2025<\/p>

To mark International ME\/CFS Day on 12 May (external link<\/a><\/span>) the ME\/CFS Research Foundation and Risklayer (a risk modelling company) are publishing a joint study that has, for the first time, determined current data on the prevalence and social costs of Long COVID and ME\/CFS in Germany. The study estimates the total annual social costs of Long COVID and ME\/CFS in Germany at around 63.1 billion euros \u2013 as of 2024. This corresponds to approximately 1.5% of gross domestic product. According to the report, the total costs since the start of the pandemic (2020-2024) amount to over 250 billion euros.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Over 1.5 million patients in Germany<\/strong>
According to the study, there were around 871,000 active Long COVID and 650,000 ME\/CFS cases in Germany in December 2024. In total, more than 1.5 million people in Germany are affected by these severe, chronic multisystemic diseases, for which there is currently no effective treatment or cure. Both diseases often lead to permanent functional limitations and incapacity to work.<\/strong><\/p>

Personal impact and economic burden
Long COVID and ME\/CFS result in the loss of everyday life function, work and social participation for many patients. Young people are often no longer able to continue their education. Family carers take on a large part of the care under great strain, all while travelling long distances to seek diganosis and treatment.
At a societal level, there are also considerable costs: for medical care, nursing care, loss of work, social benefits and lost tax revenue. Companies suffer productivity losses and purchasing power is lost.<\/p>

Infection incidence underestimated - diseases continue to increase<\/strong>
Although the pandemic is considered to be over, the report uses innovative measurement methods and data collection to show that SARS-CoV-2 continued to circulate in several waves of infection in 2024. This \"hidden\" infection pattern has continued to contribute to the emergence of new Long COVID and ME\/CFS cases. A decline in the number of cases is not foreseeable.<\/p>

Research expenditure disproportionate to the damage<\/strong>
Joerg Heydecke, Managing Director of the ME\/CFS Research Foundation and co-author of the study, warns:
\"The calculated damage of 63 billion Euros is currently offset by only 15-20 million Euros a year in public funding for diagnostics and therapy research. This is neither medically nor economically justifiable. A targeted and sustainable expansion of biomedical research could avoid considerable costs in just a few years - and give hundreds of thousands of patients new prospects for life and work.\"<\/em><\/p>

Aim of the study: initiate debate, improve care<\/strong>
With the report and the specially-developed data model, the ME\/CFS Research Foundation and Risklayer want to initiate a broad debate on the occasion of International ME\/CFS Day: How can the healthcare system, how can policymakers respond appropriately to the growing scale of post-infectious diseases? One thing is clear: the investments made to date are far from sufficient.<\/p>

Call from the scientific community: strengthen clinical research now<\/strong>
Prof. Dr Carmen Scheibenbogen (Charit\u00e9 University Medicine Berlin) emphasises:
\"These figures show how high the social damage caused by Long COVID and ME\/CFS is. Without effective therapies, the costs will remain high in the long term. However, current research results already show initial therapeutic successes and prospects. Further therapeutic approaches should be clinically trialled as soon as possible. We urgently need more financial support for this, all the more urgently as the USA is unfortunately trying to stop most research approaches and planned therapy studies. Determined investment in biomedical research, especially clinical research, would probably make real prospects of a cure possible for some of the patients in a few years' time.\"<\/em><\/p>

About the methodology of the study<\/strong>
The study combines data from emergency departments (DGINA), intensive care units (DIVI register), wastewater measurements (AMELAG) and international research findings. The model developed calculates societal damage on the basis of proven methods for disaster impact assessment - including economic, medical and social effects at various levels. The team behind the report incorporated patient and policy perspectives, and included experts from Karlsruhe Institute of Technology, the Australian National University, and the University of Adelaide.<\/p>

Healthcare emergency for ME\/CFS: an untenable situation<\/strong>
ME\/CFS has been recognised by the WHO since 1969, but is still largely ignored in Germany. Diagnosis is complex, effective therapies are lacking, symptomatic medication is rarely prescribed and hardly ever reimbursed.
In 2024, there were only very few specialised outpatient clinics in Germany. Many patients are permanently unable to work or in need of care. Their medical care and social security is often precarious.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

All information and data from the study are available on our website (in German and English):
https:\/\/mecfs-research.org\/costreport-long-covid-and-mecfs\/<\/u><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t
Graphics from the study \u2018The rising costs of Long Covid and ME\/CFS in Germany\u2019 available for download. Use for editorial purposes free of charge. All rights reserved: ME\/CFS Research Foundation.<\/figcaption>\n\t\t\t\t\t\t\t\t\t\t<\/figure>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tDownload press release (PDF, German )<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tDownload graphics from the study<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tDownload the report<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Press contact<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Thank you for your interest. Please feel free to contact us, sign up to our press mailing list and subscribe to our newsletter.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Petra\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Petra Dohrendorf
e-Mail: presse@mecfs-research.org<\/a><\/span>
phone: +49-179-1419112<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRegister for press mailing list<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tSubscribe to newsletter<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Further information on ME\/CFS, the foundation and current media coverage can be found in the press section of our website: https:\/\/mecfs-research.org\/press\/\u00a0<\/p>

Donation info<\/strong>: https:\/\/mecfs-research.org\/spenden\/<\/a><\/span><\/p>

Donation account<\/strong>: DE35 2004 0000 0628 5316 00 (Commerzbank)<\/p>

ME\/CFS Research Foundation is a non-profit limited liability company and fulfils the statutory requirements according to \u00a7\u00a7 51, 59, 60 and 61 AO (German tax laws). It may issue donation receipts within the meaning of Section 10b of the German Income Tax Act.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

About ME\/CFS Research Foundation<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The non-profit ME\/CFS Research Foundation, based in Hamburg, funds and supports biomedical research into ME\/CFS (myalgic encephalomyelitis\/chronic fatigue syndrome) and Long COVID. The aim is to develop diagnostic and therapeutic approaches to improve the current inadequate standard of care. The foundation works closely with researchers and ME\/CFS patient organisations.<\/p>

Due to a lack of research to date, there is still no effective treatment for these common and serious multisystemic diseases. The foundation funds research projects, connects researchers, ensures transparency regarding research progress, and provides facts and resources to raise awareness.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

About Risklayer<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Risklayer is a Karlsruhe-based consultancy specialising in risk analysis and risk management, with many years of experience in modelling critical events and natural disasters (e.g. geophysical and meteorological events, conflicts). Its clients include numerous governments, NGOs and companies worldwide. The company has offices in Germany and Australia.<\/p>

During the COVID-19 pandemic, it provided researchers, the media and public authorities with independent, data-driven analyses, including daily infection figures for Germany.<\/p>

Homepage: https:\/\/www.risklayer.com<\/a><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

About ME\/CFS (myalgic encephalomyelitis\/chronic fatigue syndrome) and long COVID:<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

ME\/CFS (Myalgic Encephalomyelitis \/ Chronic Fatigue Syndrome) is a chronic, severe multisystemic condition characterised by a wide range of disorders, primarily affecting the nervous and immune systems. ME\/CFS is predominantly post-infectious in origin, including as a consequence of COVID-19. It is the most severe form of Long COVID. People with ME\/CFS experience pronounced physical and cognitive symptoms, a very low quality of life and often a high degree of disability. Between 60 and 75 per cent of all sufferers are unable to work, and many are confined to their homes or beds. The key symptom is severe exercise intolerance with a worsening of symptoms following everyday activities (post-exertional malaise, or PEM for short). Due to the current lack of biomarkers, diagnosing ME\/CFS is only possible through a detailed medical history and multidisciplinary diagnostic process to rule out other conditions. Many doctors lack the necessary expertise. It often takes years for those affected to receive a diagnosis. To date, there is no effective treatment. Adults with ME\/CFS currently have little prospect of recovery and reintegration into working life. The prognosis is better for children and young people, yet long-term absences from school are the norm. For most sufferers, participation in normal life\u2014including work, education, friends, sport, hobbies, etc.\u2014is not possible.<\/p>

In Deutschland lag die Zahl der Menschen, die mit ME\/CFS leben, im Jahr 2025 bei mehr als 657.000. Ein Teil der durch COVID-19 an Long COVID bzw. Post-COVID-Syndrom erkrankten Personen erf\u00fcllt die Diagnosekriterien f\u00fcr ME\/CFS. Bereits vor der COVID-19-Pandemie lebten etwa 400.000 Menschen in Deutschland mit ME\/CFS. Weltweit liegt die Zahl der Betroffenen bei weit \u00fcber 40 Millionen. Die medizinische Versorgungslage der Erkrankten ist ungen\u00fcgend. Oft kommt es zu Fehldiagnosen und daraus resultierenden Folgesch\u00e4den.<\/p>

Die hohe Zahl der Betroffenen ist f\u00fcr alle Bereiche der Versorgung sowie auch \u00f6konomisch, durch den krankheitsbedingten Ausfall von Ausbildungszeit und Arbeitskraft, ein zunehmend kritischer Faktor.<\/p>

All the figures and sources mentioned can be found on our website: https:\/\/mecfs-research.org\/was-ist-me-cfs<\/a><\/span><\/p>

\u00a0<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

PressEmitteilung Gesellschaftliche Kosten durch Long COVID und ME\/CFS stark untersch\u00e4tzt \u2013 63 Milliarden Euro allein in 2024 Hamburg, 12. Mai 2025 Anl\u00e4sslich des Internationalen ME\/CFS-Tags am 12. Mai (externer Link) ver\u00f6ffentlichen die Stiftung ME\/CFS Research Foundation und Risklayer (ein Unternehmen f\u00fcr Risikomodellierung)\u00a0eine gemeinsame Studie, die erstmals aktuelle Daten zur H\u00e4ufigkeit und den gesellschaftlichen Kosten von […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":8866,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-12349","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/pages\/12349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/comments?post=12349"}],"version-history":[{"count":25,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/pages\/12349\/revisions"}],"predecessor-version":[{"id":16872,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/pages\/12349\/revisions\/16872"}],"up":[{"embeddable":true,"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/pages\/8866"}],"wp:attachment":[{"href":"https:\/\/mecfs-research.org\/en\/wp-json\/wp\/v2\/media?parent=12349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}